type: timeline_event
Acting CDC Director Jim O'Neill signs a decision memorandum reducing recommended childhood vaccinations from 17 to 11 diseases, implementing a December 5, 2025 Presidential Memorandum from Donald Trump directing review of international vaccination practices. The changes eliminate universal recommendations for rotavirus, COVID-19, influenza, hepatitis A, hepatitis B, and meningococcal vaccines, reclassifying them as either "high-risk only" or requiring "shared clinical decision-making" between parents and providers. The new three-tier framework designates only 11 vaccines for all children (diphtheria, tetanus, whooping cough, Haemophilus influenzae type b, pneumococcal disease, polio, measles, mumps, rubella, HPV, and chickenpox), reducing HPV vaccination to a single dose.
The restructuring bypasses the standard evidence-based process involving the CDC's Advisory Committee on Immunization Practices (ACIP), vaccine manufacturers, and public health stakeholders, implementing changes without formal public comment or scientific input from U.S. pediatric and infectious disease experts. Dr. Demetre Daskalakis, former director of CDC's National Center for Immunization and Respiratory Diseases, states the changes "undermine both scientific rigor and transparency." Sen. Bill Cassidy (R-La.), a physician and chair of the Senate health committee, warns "changing the pediatric vaccine schedule based on no scientific input on safety risks and little transparency will cause unnecessary fear for patients and doctors, and will make America sicker."
O'Neill, serving as both HHS Deputy Secretary and Acting CDC Director, functions as RFK Jr.'s top aide and has amplified anti-vaccine messaging while championing departure from the World Health Organization. Legal experts question whether the administration possesses authority to implement such major policy changes without formal rulemaking under the Administrative Procedure Act, which prohibits federal agencies from taking actions that are "arbitrary and capricious" without evidence-based foundations. The changes occur weeks after Kennedy pledged during his confirmation hearings not to cut vaccine funding or alter official vaccine recommendations—a promise he violates by pulling back $11 billion in COVID-era grants funding local health department vaccination programs and ordering cancellation of $500 million in mRNA vaccine research in August 2025.
Dr. Jason Schwartz, vaccine expert at Yale School of Public Health, warns the reclassification creates "widespread confusion about when those 'special-category' vaccines should be used, which will doubtlessly mean fewer kids will get those vaccines." The demoted vaccines protect against severe illnesses including hepatitis A and B, influenza, meningitis, respiratory syncytial virus, and rotavirus—diseases that previously warranted universal pediatric protection. While all vaccines remain technically available and covered by insurance through "shared clinical decision-making" provisions, Medicaid, Children's Health Insurance Program, and Vaccines for Children program, public health experts predict the categorical changes will dramatically reduce vaccination rates. The American Academy of Pediatrics, representing over 70,000 pediatricians nationwide, maintains its own separate childhood vaccination schedule differing from CDC's new recommendations. HHS officials announce placebo-controlled trials examining vaccine timing and long-term effects are beginning at CDC, FDA, and NIH—studies that raise ethical concerns among medical professionals regarding withholding proven protective interventions from children.